跳至主要内容
临床试验/NCT04687150
NCT04687150招募中不适用

Fecal Microbiota Transplantation in Newly Diagnosed Ulcerative Colitis Patients

Turku University Hospital1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
1
主要终点
Modified gut microbiota composition

研究概览

简要总结

In this FinUC study we are trying to find out the efficacy and safety of the Fecal microbiota transplantation (FMT) in newly diagnosed active ulcerative colitis patients. The study group with newly diagnosed active ulcerative colitis receive an FMT via colonoscopy from a tested general donor, frozen and thawed from a fecal bank at week 0 and at week 4 as an enema at the study nurse´s visit. The control group will be given colored water. The main aim of the FinUC study is to determine how the FMT change of the gut microbiota composition in newly diagnosed active ulcerative colitis patients. The other aim is to determine efficacy and mechanisms of fecal microbiota transplantation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

e

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Over 18 years
  • •Active newly diagnosed colitis (Mayo score <11)
  • •Signed informed consent

排除标准

  • •Fulminant severe colitis (Mayo score 11-12 or Truelove and Witts criteria)
  • •Gastrointestinal infection
  • •Pregnancy
  • •Antibiotic therapy at the baseline
  • •On-going probiotic medication
  • •Unable to provide signed informed consent

研究组 & 干预措施

The control group

Placebo Comparator

The control group will be given colored water at same timepoints

干预措施: Colored water (Other)

The study group

Active Comparator

The study group with newly diagnosed active ulcerative colitis receive an FMT via colonoscopy from a tested general donor, frozen and thawed from a fecal bank at week 0 and at week 4 as an enema at the study nurse´s visit

干预措施: Fecal microbiota transplantation (Other)

结局指标

主要结局

Modified gut microbiota composition

时间窗: at week 12

Increased species richness and alfa-diversity

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Kimmo Salminen

MD, PhD, Specialist in Gastroenterology

Turku University Hospital

研究点 (1)

Loading locations...

相似试验